Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Dried Blood Spot Test Reliably Detects Congenital Cytomegalovirus at Birth

By LabMedica International staff writers
Posted on 29 Sep 2025

Congenital cytomegalovirus (cCMV) is one of the most common infections passed from mother to child during pregnancy, affecting about 1 in 200 newborns. More...

While many infants born with cCMV experience no lasting effects, around 20% face birth defects or long-term complications such as hearing loss and developmental delays. Early identification is essential, yet traditional tests that rely on saliva or urine samples can be cumbersome, costly, and stressful for families. Researchers have now confirmed a simpler method that can detect most cases at birth.

Scientists at the University of Minnesota Medical School in Minneapolis (Minnesota, MN, USA) evaluated the effectiveness of a PCR-based diagnostic using dried blood spots (DBS). These samples are already collected routinely in newborn screening programs, making them a practical and accessible tool. By applying molecular testing to DBS, the team aimed to streamline screening while ensuring reliability, reducing the need for additional sample collection.

The study, published in JAMA Network Open, found that the DBS test detects more than 90% of symptomatic CMV cases. This level of accuracy matches other methods while avoiding extra burdens on families and hospitals. Importantly, the test can identify infants most at risk for complications, allowing timely follow-up, interventions, and developmental monitoring to improve long-term outcomes.

These findings highlight the potential of integrating DBS-based testing into universal newborn screening programs. Minnesota already became the first U.S. state to mandate cCMV screening for all newborns in 2023, spurred by advocacy and prior research at the University of Minnesota. The new results provide strong evidence to expand adoption nationwide and internationally, with the goal of catching infections earlier and improving care strategies.

Researchers see room for refinement, aiming to boost predictive accuracy even further. With improvements, the test could potentially achieve near-perfect detection, enhancing its role in guiding interventions and policy. Broad implementation of this approach could significantly reduce the burden of cCMV by ensuring affected infants receive support from the earliest stages.

“These findings define a new path forward and a new approach to newborn care, but improvements can be made,” said Mark Schleiss, MD, professor at the University of Minnesota Medical School. “We have a test that has over 90% predictive ability to find those CMV babies that need extra help – let’s improve the test and aim for 100% accuracy.”

Related Links:
University of Minnesota Medical School


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.